You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
Considerations on the poor discriminatory power of the FRANCE-2 risk score: Authors' reply

https://doi.org/10.1136/heartjnl-2014-307208

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors BI drafted the letter. CL, AV and MG reviewed and amended its content.

    • Competing interests BI has received consultant fees from Abbott, Boehringer Ingelheim, Bayer, Valtech and speaker's fees from Edwards Lifesciences. AV is member of Advisory Board for Medtronic, Abbott, Valtech and Boehringer Ingelheim and has received speaker's fees from Edwards Lifesciences and Siemens.

    • Ethics approval Institutional review board of the French Ministry of Health.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles